Sl. No. | Funding Agent | Title of the Project | Amount (Rs) | Role | Status |
Ongoing Projects |
28 | Scheme for Promotion of Academic & Research Collaboration (SPARC) Prof. Swati Biswas (PI) Prof. Adam Mechler (La Trobe, Australia) Prof. Jimmy Hsia (NTU, Singapore). | Formulation-based strategy to design membrane targeting antimicrobial peptide-based therapeutics for cancer and eye infections | Rs. 71.16 Lakhs | Co-PI | Recommended (01, April 2024) (2 years) |
27 | Department of Biotechnology (DBT) under Joint DBT-NMPB, Ministry of AYUSH Call for Proposals on Biotech Interventions in Medicinal Plants [Dr. Vidya Rajesh, Dept of Biology and Dr. Onkar Kulkarni, Dept of Pharmacy] | Molecular Studies on Bacopa monnieri to evaluate the modulation of neuronal receptors for schizophrenia using cell based and mouse models: Submitted on January 30_2020 | Rs. 30 Lakhs | Co-PI | May 2024 to April 2027 (3 years) |
26 | Hetero Lab Limited, R&D Jeedimetla, Hyderabad, Telangana – 500037 India. [Dr. Swati Biswas] | Human serum albumin –based nanoparticles as an
antiproteosome therapy for the treatment of advanced
metastatic triple negative breast cancer | Rs. 5.0 Lakhs | Joint PI | Sanctioned 2024-2027 (3 years) |
25 | Department of Biotechnology (DBT), Govt. of India. [Dr. Swati Biswas, Dept. of Pharmacy] | 3D-Bioprinted Contact Lens Embedding Host-Defense Peptide S100A12 as Precision Medicine for Bacterial Keratitis | 39.10 Lakhs | Co-PI | Sanctioned (1.5 years) |
24 | Indian Council of Medical Research (ICMR), Govt. of India [Dr. Swati Biswas, Dept of Pharmacy] | Revolutionizing Phototherapy with Hypoxia-Reversing Photothermal/ Photodynamic Nanoparticles-Laden In Situ Gel for Non-Invasive Tumor Ablation in Oral Cancer | 53.13 Lakhs | Co-PI | Sanctioned (3 years) |
23 | Indian Council of Medical Research (ICMR), Govt. of India [Dr. Swati Biswas, Dept. of Pharmacy] | Antibacterial Nanozyme-Laden in situ Light-Responsive Hydrogel for Tissue Regeneration and Quorum-Sensing Inhibition to Revert Antimicrobial Resistance in Diabetic Foot Ulcers | 48.02 Lakhs | Co-PI | Sanctioned (3 years) |
22 | Scheme for Transformational and Advanced Research in Sciences (STARS) for promoting translational, India-centric research in Sciences, to be implemented and managed by Indian Institute of Science (IISc), Bangalore [Dr. Swati Biswas, Dept of Pharmacy and Dr. Sayan Das, Dept. of Mech. Engg] | Carbon dioxide-fueled Janus Motors for Targeted Delivery of Therapeutic Cargo in Helicobacter pylori Infection | 43.15 Lakhs | Co-PI | Sanctioned Jan 2024 (3 years) |
21 | Indian Council of Medical Research (ICMR), Govt. of India. (Proposal ID: IIRP-2023-5411) [Dr. Chanchal Chakraborty, Dept. of Chemistry] | Development of Self-Powered Electrochromic Smart Display for Visual Detection of Folate Receptor Overexpressed Cancer Cells | Rs. 41 Lakhs | Co-PI | Sanctioned Feb 1, 2024 (3 years) |
20 | Department of Science and Technology, Government of India (CRG-SERB) File Number: CRG/2023/003045 [Dr. Tanmay Chatterjee, Dept. of Chemistry] | Electrochemical green synthesis of medicinally potential organo-chalcogenides and chalcogenoxides and evaluation of their anti-cancer activities in search of novel anti-cancer agents | Rs. 43.486Lakhs | Co-PI | Jan 19, 2024 ( 3 years) |
19 | Indian Council of Medical Research (ICMR), Govt. of India | Development of epigenetic modulators as therapeutics for cognitive deficit associated with psychosis using novel selective histone deacetylase-3 inhibitors | 34.84 Lakhs | PI | Ongoing 25.03.2023 – 24.03.2026 (3 years) |
18 | Indian Council of Medical Research (ICMR), Govt. of India [Dr. Onkar Kulkarni, Dept. od Pharmacy] | HDAC3 and its functional role in the progression of cognitive deficits as a secondary complication to chronic kidney disease. | 31.16 Lakhs | Co-PI | Ongoing; 01.03.2023 to 28.02.2026 (3 years) |
17 | Indian Council of Medical Research (ICMR), Govt. of India {DR. Swati Biswas, Dept of Pharmacy] | Tailor-made, Tumor-Targeted Vitaprotein Nanoparticles of Lapatinib and Letrozole as NanoChemo-Cocktail. for Hormone-Receptor-Amplified Advanced Metastatic Breast Cancers Treatment. | 28.82 Lakhs | Co-PI | Ongoing; 27.01.2023 – 26.01.20226 (3 Yrs) |
16 | Indian Council of Medical Research (ICMR), Govt. of India [Dr. Nilanjan Dey, Dept. of Chemistry] | Design and development of portable acidosis kit for the rapid, trace-level detection of Ketone bodies in biological samples | 34.366 Lakhs (Co-PI: Rs. 6 Lakhs) | Co-PI | Ongoing; 01.04.2023– 31.03.2026 (3 Yrs) |
15 | Department of Health Research (DHR-ICMR). Government of India | Development of Epigenome Targeted Therapeutics with Improved Selectivity and Drug-ability for the Treatment of Cancer | 30.483 Lakhs | PI | Ongoing (15.12.2021 – 14.12.2024; ( 3 Years)) |
14 | DBT-BUILDER (Boost to University Interdisciplinary Life Science Departments for Education and Research). Government of India | Interdisciplinary Life Science Programme for Advanced Research and Education | 300 Lakhs | PI | Ongoing (22.07. 2021 – 21.07.2026 [5 years] |
13 | Council of Scientific and Industrial Research (CSIR), Government of India [Dr. Tanmay Chatterjee, Chemistry Dept] | Development of Cost-effective, Electrophilic Trifluoromethylating Reagents and Their Application to the Syntheses of New Classes of Medicinally Potential Trifluoromethylated Heterocycles | 25 Lakhs | Co-PI | Ongoing (01.04.2021 – Ongoing 31.03.2024 (3 Yrs) |
Completed Projects |
12 | BITS-Pilani Hyderabad Campus | Validation of therapeutic activity in preclinical models | 20 Lakhs | PI | Jan 2023 to Dec 2023 |
11 | Council of Scientific and Industrial Research (CSIR) Government of India | Bifunctional Gene-Expression Modulating Chemotherapeutic Agents as Improved Treatment Strategy for Cancer | 26.06 Lakhs | PI | Completed( 2019-2022) |
10 | Department of Science and Technology, Government of India (SERB-DST) | Near-Infrared Light Degradable Nanomicellar Chemo-Photodynamic Therapy using Aerobic Chlorin e6 Conjugate for Oropharyngeal Carcinomas | 30.72 | Co-PI | Completed (2019-2022) |
9 | Indian Council of Medical Research (ICMR), Govt. of India | Functional role of histone deacetylase 6 (HDAC6) in the progression of oral squamous cell carcinoma: regulation of IL-1 beta expression, autophagy and epithelial-mesenchymal –transition (EMT) | 26 Lakhs | Co-PI | Completed(9.9.2019-8.9.2022) |
8 | Dr. Reddy’s Laboratory (DRL), Hyderabad | Formulation development and physico-chemical/in vitro/in vivo characterization of a nano-suspension formulation of an anticancer drug. | 8.01 Lakhs | PI | Completed (2018-2022) |
7 | Department of Science and Technology, Government of India (SERB-DST) | Design, Synthesis and Biological Evaluation of HDAC3 Selective Inhibitors as Long Term Memory Enhancers | 29.87 Lakhs | PI | Completed (28.08.2017-27.08.2021 |
6 | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (SPARC), India | Chemically modified epigenome targeted anticancer drug development | 29 Lakhs | PI | Completed (2016-2018) |
5 | Daewoong Pharmaceuticals, Seoul, Republic of Korea | Development for sustained release injectable formulations | 22 Lakhs | PI | Completed (2015-2017) |
4 | Department of Biotechnology (DBT), Government of India | Cell penetrating peptide octa-arginine anchored, multifunctional poly(amidoamine) dendrimer to promote delivery of chemotherapeutics in cancer | 37 Lakhs | Co-PI | Completed (2014-2017) |
3 | Additional Competitive Research Grant: Birla Institute of Technology and Science-Pilani | Design and Development of Isoform Selective HDAC3 Inhibitors for the Enhancement of Long-term Memory | 9 Lakhs | PI | Completed (2015-2017) |
2 | Department of Science and Technology (DST), Government of India (Indo-Belarus joint proposal). | Tumor targeted nanomedicines for photodynamic therapy | 10 Lakhs | Co-PI | Completed (2015-2017) |
1 | Research Initiation Grant: Birla Institute of Technology and Science-Pilani at Hyderabad Campus | Development of Cognitive Enhancers that Inhibit Histone Deacetylase Activity and Modulate Chromatin-mediated Neuroplasticity | 2 Lakhs | PI | Completed (2013-2015) |
